OnKure Therapeutics (OKUR) Misses Q1 EPS by 111c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 rises; Apple and Palantir set to report results
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Why has the market become so unforgiving of AI earnings?
- EchoStar rises on report SpaceX in talks to buy Boost Mobile or tap its network
Tweet
Share
E-mailGet Alerts OKUR Hot Sheet
Join SI Premium – FREE
OnKure Therapeutics (NASDAQ: OKUR) reported Q1 EPS of ($1.11).
For earnings history and earnings-related data on OnKure Therapeutics (OKUR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Loews Corp. (L) Reports Q3 EPS of $1.50
- Raymond James Upgrades Lumentum (LITE) to Strong Buy, 'Overreaction to Marvell Offer'
- BB&T Corp. (BBT) 4200 contracts of December 35 calls trade, share price up 2.7%
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
